Immunologic Monitoring (IM)
- Institution
- UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI
- Principal investigator
- Maria G Castro
- Funding
- $117K
- Duration
- 1997–2028
Moonbase score
Still being scored
Abstract
The Immune Monitoring Shared Resource (IM-SR) was established by the University of Michigan (U-M) Rogel Cancer Center (Rogel) in 1999 and has been continuously funded by the Cancer Center Support Grant (CCSG) since 2001. The goal of IM-SR is to foster, facilitate, and support basic, translational, clinical, and population science researchers who seek to enhance understanding of cancer immune response and therapies. IM-SR benefits from the leadership of Co-Directors who have distinct yet complimentary expertise. Together, they provide leading-edge scientific knowledge and front-line researcher perspectives as they guide SR services, equipment, and technology. Users pursue basic science and translational research, with the goal of advancing knowledge of the role of the immune and inflammatory responses in cancer initiation, progression, and metastasis, as well as therapeutic efficacy and resistance.
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF MICHIGAN AT ANN ARBOR
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of Michigan at Ann ArborNot yet scored
Neuro-immune mechanisms in mutant IDH1 gliomas
Maria G Castro · $659K · 2025–2029
- NIH · University of Michigan at Ann ArborNot yet scored
Uncover the role of H3.3-G343R mutation in shaping the DNA damage response, anti-tumor immunity and mechanisms of resistance in glioma.
Maria G Castro · $458K · 2022–2026
- NIH · University of Michigan at Ann ArborNot yet scored
Training Program in Tumor Microenvironment
Maria G Castro · $347K · 1997–2029